DBV Technologies S.A. (NASDAQ:DBVT)’s stock price rose 6.8% during trading on Thursday . The company traded as high as $6.01 and last traded at $5.96. Approximately 318 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 678,058 shares. The stock had previously closed at $5.58.
Several research analysts recently issued reports on DBVT shares. Societe Generale cut shares of DBV Technologies from a “hold” rating to a “sell” rating in a report on Friday, January 22nd. The Goldman Sachs Group increased their price target on shares of DBV Technologies from $4.00 to $7.00 in a report on Monday, January 18th. Citigroup increased their price target on shares of DBV Technologies from $4.00 to $8.00 in a report on Friday, January 15th. Zacks Investment Research raised shares of DBV Technologies from a “sell” rating to a “hold” rating in a report on Friday, April 2nd. Finally, SVB Leerink reissued an “outperform” rating on shares of DBV Technologies in a report on Friday, March 12th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $7.11.
The company has a debt-to-equity ratio of 0.08, a current ratio of 4.28 and a quick ratio of 4.22. The firm’s 50-day simple moving average is $5.47 and its two-hundred day simple moving average is $3.66. The company has a market capitalization of $657.04 million, a price-to-earnings ratio of -2.56 and a beta of 2.91.
About DBV Technologies (NASDAQ:DBVT)
DBV Technologies SA, a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults.
Featured Article: Key terms to understand channel trading
Receive News & Ratings for DBV Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DBV Technologies and related companies with MarketBeat.com's FREE daily email newsletter.